RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
 Individual Studies |
|
|---|---|
|
|
Rattus norvegicus
-
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Authors: Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, S Yusuf, K Teo, C Anderson, J Pogue, L Dyal, I Copland, H Schumacher, G Dagenais, P Sleight
Lancet 2008 Sep 27 -
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.
Authors: William L Baker, Craig I Coleman, Jeffrey Kluger, Kurt M Reinhart, Ripple Talati, Robert Quercia, Olivia J Phung, C Michael White
Annals of internal medicine 2009 Dec 15
Thought leaders and organizations working on research involving angiotensin converting enzyme inhibitor.
- National Heart, Lung, and Blood Institute (NHLBI)
- Wake Forest University
- Mayo Clinic
- Medical University of Gdansk
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDD…
- Showa University Fujigaoka Hospital
- McMaster University
- University of Connecticut/Hartford Hospital Evidence-based Practice Ce…
- VA Medical Center
- Duke University
-
Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
conditions: Marfan Syndrome
interventions: Coversyl (perindopril)
-
Rhubarb and Angiotensin Converting Enzyme Inhibitor
conditions: Diabetic Kidney Disease
interventions: rhubarb extract ; placebo
-
Association Between Mortality and Persistent Use of Beta Blockers and Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Coronary Artery Disease
American journal. - April 09, 2009 -
High Blood Pressure Best Buys in ACE Inhibitors
Associated Content. - March 15, 2010
